The American pharmaceutical supply chain has become dangerously dependent on imports and foreign-controlled supply chains. Over the past 20 years, the country has experienced a skyrocketing rate on pharmaceutical imports and increasing foreign reliance.
Yes, reshoring manufacturing is possible. Investors will even go along for the ride, Guardian Bikes CEO Brian Riley told the Senate Small Business Committee in a hearing on May 14.
Under the so-called “Big Beautiful Bill” as passed by the House, Chinese solar companies will no longer qualify for renewable energy tax benefits under the Inflation Reduction Act (IRA) of 2022.
Some Chinese solar power inverters were allegedly found to have communication devices attached to them that were not supposed to be part of that equipment, suggesting that they can ping information back to the company’s headquarters and be used for nefarious ends, Reuters London reported on May 14.
The Trump Administration is leading a realignment on trade, moving away from a unipolar system that really had Asia as the Western world’s manufacturing hub. That is no longer feasible, or affordable.
This month’s tariff agreements with the United Kingdom and China might end up being the first deal of its kind, and the last. On Friday, President Trump reiterated that the administration could not possibly strike deals with every country, and that tariff announcements would be made over the next two to three weeks.
The U.S. must not sacrifice the chance to rebuild industrial capacity in exchange for another empty trade promise to import more American goods, as if these promises will actually materialize.
Importers continued to front-run the April ‘Liberation Day’ tariffs in March, sending the overall trade deficit up 14% over February numbers to $140.5 billion for the month, according to the Bureau of Economic Analysis (BEA) on Tuesday.
Democrats on the Economic Growth, Energy Policy, and Regulatory Affairs Subcommittee—of the House Committee on Oversight and Government Reform—are united against tariffs.
The American people, Congress, and the President have spoken. Now it’s Wall Street’s turn to decide.
